Video

R&D
Jonah Comstock interviewing Blair McNeill at Reuters Pharma USA

Reuters Pharma USA 2024 – Blair McNeill

In today's era of cell, gene, and tissue therapies, new treatments are truly game-changing, often creating an opportunity for a healthy, normal life for people who previously had no options

R&D
Jonah Comstock interview with Pierre Luzeau

Health Innovators – Pierre Luzeau

Getting a drug from idea to market is a complex process that requires a number of stakeholders, from research to development to manufacturing.

R&D
JP Morgan 2024 – Sam Deutsch

JP Morgan 2024 – Sam Deutsch

In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica

R&D
JP Morgan interview with Jonah Comstock and Marianne De Backer

JP Morgan 2024 – Marianne De Backer

Vir Biotechnology made headlines in 2021 for its work with GlaxoSmithKline on a treatment for COVID-19, and again in 2022 for its work with the US government on influenza.

R&D
JP Morgan 2024 – Katherine Stueland and Jonah Comstock

JP Morgan 2024 – Katherine Stueland

Diagnostics can be a neglected part of the treatment paradigm, but it’s hugely important for connecting patients with the right treatments.